Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

A better characterization of disinhibition in frontotemporal degeneration

Published on: 20/06/2022 Reading time: 1 min
cerveau

Thanks to an approach combining behavioral assessment and brain imaging, a study conducted by the Paris Brain Institute's FrontLAB has led to a better characterization of a major symptom of frontotemporal degeneration, disinhibition. These results, published in Neuroimage: Clinical, pave the way for a more adapted and personalized management of patients and support for their caregivers.

Disinhibition, a major symptom of frontotemporal degeneration 

Disinhibition is a symptom of many neurodegenerative diseases, in particular those affecting the frontal regions of the brain such as fronto-temporal degeneration (FTD). FTD is the second most common cause of dementia after Alzheimer's disease. They can take different forms, including a variant called "behavioral", characterized by cognitive and behavioral disorders. Disinhibition is at the heart of these behavioral changes and disorders.

Two main types of disinhibition are commonly distinguished: cognitive disinhibition, which corresponds to an inability to block (inhibit) inappropriate responses or to stop responses already underway, and behavioral disinhibition, which is manifested by the inability to repress behaviors in an environment, in social contexts or to adapt to changes in one's environment.

"Despite these two relatively well-established definitions, there is still no way to accurately assess behavioral disinhibition in people with FTD other than through caregiver-completed questionnaires. Moreover, the neuroanatomical correlates of this symptom are not clearly defined," said Delphine Tanguy, first author of the study.

LA COMBINAISON D’UNE APPROCHE SEMI-ÉCOLOGIQUE ET DE L’IMAGERIE CÉRÉBRALE

Depuis près de 10 ans, l’Institut du Cerveau développe le programme ECOCAPTURE, conduit par Bénédicte Batrancourt (Inserm) et Richard Lévy (AP-HP-Sorbonne Université), qui vise à évaluer de façon objective et quantitative les symptômes neuropsychiatriques comme l’apathie et la désinhibition en conditions proches de la vie réelle (approche semi-écologique).

Afin de mieux définir la désinhibition chez les patients atteints de DFT, l’équipe FrontLAB de l’Institut du Cerveau a utilisé l’approche d’ECOCAPTURE pour évaluer avec de nouvelles métriques comportementales, deux composantes de la désinhibition : la compulsivité et la désinhibition sociale. Ils y ont associé de l’imagerie structurelle (IRM) et des questionnaires classiques d’évaluation cognitive comme le test de Hayling (mesure les capacités d’inhibition cognitive lors des réponses verbales spontanées) et des tests de cognition sociale.

The combination of a semi-ecological approach and brain imaging

For nearly 10 years, the Paris Brain Institute has been developing the ECOCAPTURE program, led by Bénédicte Batrancourt (Inserm) and Richard Lévy (AP-HP-Sorbonne University), which aims to objectively and quantitatively evaluate neuropsychiatric symptoms such as apathy and disinhibition under conditions close to real life (semi-ecological approach).

In order to better define disinhibition in FTD patients, the FrontLAB team of the Paris Brain Institute used the ECOCAPTURE approach to assess two components of disinhibition with new behavioral metrics: compulsivity and social disinhibition. They combined structural imaging (MRI) and classical cognitive assessment questionnaires such as the Hayling test (measures cognitive inhibition abilities during spontaneous verbal responses) and social cognition tests.

A better characterization of disinhibition in FTD patients

The researchers confirm that in patients with the behavioral variant of FTD, disinhibition is manifested on both components: compulsivity and social disinhibition. Moreover, the behavioral data collected through the semi-ecological approach are consistent with the results of the cognitive tests. Compulsivity observed in patients correlates with Hayling test scores. Furthermore, both compulsivity and social disinhibition are associated with the results of the social cognition and emotion recognition tests. Finally, the imaging data allow us to distinguish two different patterns of atrophy in the frontotemporal networks depending on the subtype of disinhibition: social disinhibition or compulsivity.

These results confirm the interest of the semi-ecological approach for the assessment of disinhibition. By characterizing more precisely the type of disinhibition affecting a patient, we can set up better management strategies for the patient and also support his or her caregiver, whose quality of life can be heavily impacted by this type of symptom

Lara Migliaccio Inserm

Source : An ecological approach to identify distinct neural correlates of disinhibition in frontotemporal dementia. Tanguy D, Batrancourt B, Estudillo-Romero A, Baxter JSH, Le Ber I, Bouzigues A, Godefroy V, Funkiewiez A, Chamayou C, Volle E, Saracino D, Rametti-Lacroux A, Morandi X, Jannin P, Levy R, Migliaccio R; ECOCAPTURE study group. Neuroimage Clin. 2022 Jun 7

Our news on the subject

Interneurones. Crédit : UCLA Broad Stem Cell Research Center.
Stimulating specific neurons in the striatum stops compulsive behaviour
What if we could resist compulsions? These irrational behaviours, particularly common in obsessive-compulsive disorder (OCD), are hard to suppress. At Paris Brain Institute, Éric Burguière's team shows that we can anticipate them and block them ...
09.10.2024 Research, science & health
Les nerfs moteurs présents dans la moelle épinière se projettent vers la périphérie, où ils entrent en contact avec les muscles, formant des connexions appelées jonctions neuromusculaires. Crédit : James N. Sleigh.
Ultrasound show unexpected effects on motor neuron disease
Over the past fifteen years, neurosurgeons have been perfecting a fascinating technique: using ultrasound to temporarily open the blood-brain barrier to facilitate the action of therapeutic molecules in the central nervous system. At Paris Brain ...
09.05.2024 Research, science & health
Un neurone
Rett syndrome: a new gene therapy on the way
Gene therapy could be our best chance of treating Rett syndrome, a neurological disorder that causes severe intellectual and motor impairments. At Paris Brain Institute, Françoise Piguet and her colleagues have looked closely at brain cholesterol ...
07.16.2024 Research, science & health
Lésions d’un patient à l’inclusion dans le protocole (M0) disparues après 2 ans de traitement à la Leriglitazone (M24)
The dual effect of leriglitazone in X-linked Adrenoleukodystrophy (X-ALD)
In 2023, the team led by Professor Fanny Mochel (AP-HP, Sorbonne University), a Paris brain Institute researcher, showed that daily dose of leriglitazone slow down the progression of myelopathy in patients with X-linked adrenoleukodystrophy, and ...
06.28.2024 Research, science & health
Une tête de statue de l'île de Pâques sur laquelle sont posées des éléctrodes
A multimodal approach to better predict recovery in patients with disorders of consciousness
When a patient is admitted to intensive care due to a disorder of consciousness—such as a coma—establishing their neurological prognosis is a crucial yet challenging task. To reduce the uncertainty that precedes the medical decision, a group of ...
05.30.2024 Research, science & health
Population de bactéries commensales (en rouge) dans un intestin grêle de souris. Crédit : University of Chicago
The composition of the gut microbiota could influence decision-making
The way we make decisions in a social context can be explained by psychological, social, and political factors. But what if other forces were at work? Hilke Plassmann and her colleagues from the Paris Brain Institute and the University of Bonn show ...
05.16.2024 Research, science & health
See all our news